An Inhibitor of NF-κB and an Agonist of AMPK: Network Prediction and Multi-Omics Integration to Derive Signaling Pathways for Acteoside Against Alzheimer’s Disease. This evidence concerns the gene NFKB1 and early-onset autosomal dominant Alzheimer disease.